What is NDC 51662-1649?

51662-1649 is the product NDC for Hydroxyzine Hydrochloride, Hydroxyzine dihydrochloride 25 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Hydroxyzine Hydrochloride?

194 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Hydroxyzine Hydrochloride NDC 51662-1649

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1649Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1649Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1649-3	5166216490351662164903	25 POUCH in 1 CASE (51662-1649-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1649-2) / 10 mL in 1 VIAL, MULTI-DOSEMarketed from Sep 30, 1990

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydroxyzine Hydrochloride
Generic name (nonproprietary): hydroxyzine hydrochloride
Active ingredients: Hydroxyzine dihydrochloride — 25 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 087408
Marketing start: Sep 30, 1990
Listing expires: Dec 31, 2026
Other FDA classes: Histamine Receptor Antagonists (Mechanism)
Identifiers: Product ID 51662-1649_19869100-35c6-c014-e063-6294a90a4f11SPL ID 19869100-35c6-c014-e063-6294a90a4f11SPL set ID 16a63845-6619-293b-e063-6394a90a0a5cRxCUI 995270UNII 76755771U3
Pharmacologic class: Antihistamine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662164903 followed by a unit qualifier and the quantity

Package 51662-1649-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 28, 2024.

Indications (excerpt from the label)

The total management of anxiety, tension, and psychomotor agitation in conditions of emotional stress requires in most instances a combined approach of psychotherapy and chemotherapy. Hydroxyzine has been found to be particularly useful for this latter phase of therapy in its ability to render the disturbed patient more amenable to psychotherapy in long term treatment of the psychoneurotic and psychotic, although it should not be used as the sole treatment of psychosis or of clearly demonstrated cases of depression. Hydroxyzine is also useful in alleviating the manifestations of anxiety and tension as in the preparation for dental procedures and in acute emotional problems. It has also been …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1649

What is NDC 51662-1649?: 51662-1649 is the product NDC for Hydroxyzine Hydrochloride, Hydroxyzine dihydrochloride 25 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Hydroxyzine Hydrochloride.
What is the active ingredient?: Hydroxyzine dihydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Hydroxyzine Hydrochloride?: 194 other product NDCs are listed under this name. See all Hydroxyzine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Hydroxyzine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Hydroxyzine Hydrochloride	Hydroxyzine hydrochloride 10 mg/5mL	SolutionOral	Advagen Pharma Limited	72888-218	72888-0218-13
Hydroxyzine hydrochloride	Hydroxyzine hydrochloride 50 mg/1	TabletOral	Coupler LLC	67046-0566	67046-0566-03
Hydroxyzine hydrochloride	Hydroxyzine hydrochloride 10 mg/1	TabletOral	Coupler LLC	67046-0833	67046-0833-03
Hydroxyzine Hydrochloride	Hydroxyzine dihydrochloride 25 mg/1	Tablet, Film coatedOral	Advanced Rx of Tennessee, LLC	80425-0590	80425-0590-0180425-0590-0280425-0590-03
Hydroxyzine hydrochloride	Hydroxyzine hydrochloride 50 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-039	87441-0039-01
Hydroxyzine Hydrochloride	Hydroxyzine hydrochloride 10 mg/5mL	SolutionOral	Saptalis Pharmaceuticals, LLC.	71656-090	71656-0090-16
Hydroxyzine Hydrochloride	Hydroxyzine dihydrochloride 25 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1311	67046-1311-03
Hydroxyzine hydrochloride	Hydroxyzine dihydrochloride 25 mg/1	TabletOral	Coupler LLC	67046-0713	67046-0713-03
Hydroxyzine Hydrochloride	Hydroxyzine dihydrochloride 10 mg/5mL	SolutionOral	ANI Pharmaceuticals, Inc.	70954-912	70954-0912-10
Hydroxyzine Hydrochloride	Hydroxyzine hydrochloride 25 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-2148	55154-2148-00

All 195 Hydroxyzine Hydrochloride NDCs

Other NDCs under ANDA 087408

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 087408
Product	Strength	Form · route	Labeler	Product NDC
Hydroxyzine	Hydroxyzine dihydrochloride 50 mg/mL	Injection, SolutionIntramuscular	Henry Schein, Inc.	0404-9878
Hydroxyzine Hydrochloride	Hydroxyzine dihydrochloride 50 mg/mL	Injection, SolutionIntramuscular	Henry Schein, Inc.	0404-9877
Hydroxyzine Hydrochloride	Hydroxyzine dihydrochloride 25 mg/mL	Injection, SolutionIntramuscular	American Regent, Inc.	0517-4201
Hydroxyzine Hydrochloride	Hydroxyzine dihydrochloride 50 mg/mL	Injection, SolutionIntramuscular	American Regent, Inc.	0517-5601
Hydroxyzine Hydrochloride	Hydroxyzine dihydrochloride 50 mg/mL	Injection, SolutionIntramuscular	American Regent, Inc.	0517-5602